[ Price : $8.95]
FDA and Repros will meet 11/8 to review the companys plans for two Androxal Phase 3 studies to treat hypogonadism.[ Price : $8.95]
FDA principal deputy commissioner Josh Sharfstein tells a Congressional hearing that San Juan District director Maridalia Torres i...[ Price : $8.95]
The Alliance for a Stronger FDA says it will continue to push for higher agency funding, especially given the potential for a hiri...[ Price : $8.95]
FDA orders drug manufacturers of unapproved single-ingredient oral colchicine, a medication used for treating gout and familial Me...[ Price : $8.95]
FDA grants iCo Therapeutics an orphan drug designation for iCo-009 (oral amphotericin B) for treating visceral leishmaniasis.[ Price : $8.95]
The Institute of Medicine contracts for a one-year study of health information technology in patient safety, including FDAs role.[ Price : $8.95]
The American Clinical Laboratory Association and the Genetic Alliance urge FDA to use notice and comment rulemaking to develop a r...[ Price : $8.95]
CDRH 510(k) staff director Heather Rosecrans retires from the agency and joins other former FDAers at regulatory consulting firm G...